US Broker Ratings

Quest Diagnostics (DGX) Stock Analysis: Assessing the 4.62% Upside Potential

Quest Diagnostics Incorporated (NYSE: DGX) stands as a significant player in the healthcare sector, specifically within the Diagnostics & Research industry. With a robust market capitalization of $23.01 billion, the..

Revvity, Inc. (RVTY) Stock Analysis: A Healthcare Pioneer with 24.51% Upside Potential

Revvity, Inc. (RVTY) stands out in the healthcare sector with its robust diagnostics and research offerings. Catering to a wide range of clients from pharmaceutical giants to academic institutions, Revvity..

Natera, Inc. (NTRA) Stock Analysis: Unpacking the 24.72% Potential Upside in the Diagnostics Powerhouse

Natera, Inc. (NASDAQ: NTRA), a prominent player in the healthcare sector specializing in diagnostics and research, has captured investor attention with its cutting-edge molecular testing services. Headquartered in Austin, Texas,..

Bristol-Myers Squibb (BMY) Stock Analysis: Is Its 4.15% Dividend Yield Enough for Investors?

Bristol-Myers Squibb Company (NYSE: BMY) stands as a stalwart in the healthcare sector, known for its robust portfolio in the biopharmaceutical landscape. With a market capitalization of $123.7 billion, this..

Illumina, Inc. (ILMN) Stock Analysis: Evaluating a 16% Upside Potential Amidst Strong Growth Metrics

Illumina, Inc. (NASDAQ: ILMN) stands as a towering figure in the healthcare sector, particularly within the diagnostics and research industry. Valued at a market cap of $17.86 billion, Illumina has..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Unveiling a 25.93% Potential Upside with Robust Growth Prospects

Navigating the ever-evolving landscape of healthcare innovations, Intuitive Surgical, Inc. (NASDAQ: ISRG) stands out as a stalwart in the medical instruments and supplies industry. With a market capitalization of $172.54..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Strong Buy Ratings and a Promising 48% Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a prominent player in the biotechnology sector, has captured investor attention with its innovative therapies aimed at treating life-threatening rare diseases. With a market capitalization..

Novo Nordisk A/S (NVO) Stock Analysis: Evaluating Its 9.64% Potential Upside for Investors

Novo Nordisk A/S (NYSE: NVO), a titan in the healthcare sector, continues to capture the interest of investors worldwide. With a market capitalization of $220.42 billion, the Denmark-based pharmaceutical giant..

Insulet Corporation (PODD) Stock Analysis: A 52.28% Upside Potential Beckons Investors

For investors seeking opportunities in the healthcare sector, Insulet Corporation (NASDAQ: PODD), with its focus on innovative insulin delivery systems, presents a compelling prospect. With a market cap of $17.09..

Vertex Pharmaceuticals (VRTX) Stock Analysis: A Biotech Powerhouse with 6.93% Upside Potential

Vertex Pharmaceuticals Incorporated (VRTX), a key player in the biotechnology sector, continues to capture the attention of investors with its robust pipeline and strong market presence. With a market capitalization..

Cardinal Health (CAH) Stock Analysis: A Healthcare Giant with 12.23% Upside Potential

Cardinal Health, Inc. (NYSE: CAH) is a prominent player in the healthcare sector, particularly known for its robust operations in medical distribution. With a market capitalization of $51.96 billion, this..

Zoetis Inc. (ZTS) Stock Analysis: Exploring a 20% Upside Potential in the Animal Health Sector

Zoetis Inc. (ZTS), a leader in the animal health sector, is capturing investor attention with its robust market presence and a compelling potential upside of 20.07%. With a market capitalization..

Biogen Inc. (BIIB) Stock Analysis: Navigating a 4.58% Upside Potential Amidst Healthcare Innovations

As a prominent player in the healthcare sector, Biogen Inc. (NASDAQ: BIIB) stands at the forefront of innovative drug development, specializing in therapies for neurologic and immunologic diseases. With a..

UnitedHealth Group (UNH) Stock Analysis: Examining a 24.36% Potential Upside Amidst Robust Revenue Growth

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector, stands out as a compelling investment opportunity with a notable potential upside of 24.36%. This analysis delves into the..

Amgen Inc. (AMGN) Stock Analysis: Evaluating the Performance and Growth Potential of a Biotech Giant

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, continues to assert its dominance in the drug manufacturing industry. With a sprawling market capitalization of nearly $199 billion, Amgen..

AbbVie Inc. (ABBV) Stock Analysis: A Healthcare Giant with Robust Analyst Buy Ratings and a Healthy Dividend Yield

AbbVie Inc. (NYSE: ABBV), a prominent player in the healthcare sector, stands out in the drug manufacturers industry with a significant market capitalization of $409.15 billion. Since its inception in..

Alnylam Pharmaceuticals (ALNY) Investor Outlook: Analyzing the 46% Potential Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leader in the biotechnology sector, is capturing investor attention with a significant potential upside of 46.12%. With a market capitalization of $41.7 billion, this..

Tenet Healthcare (THC) Stock Analysis: Navigating a 10.32% Potential Upside in the Healthcare Sector

Tenet Healthcare Corporation (NYSE: THC) stands as a formidable player within the U.S. healthcare industry, boasting a market capitalization of $20.42 billion. As an entity operating in the medical care..

ResMed Inc. (RMD) Stock Analysis: Evaluating a 17.79% Potential Upside for Investors

ResMed Inc. (NYSE: RMD), a prominent player in the healthcare sector, specializes in developing innovative medical devices and cloud-based software applications to manage respiratory disorders. With a market capitalization of..

IDEXX Laboratories, Inc. (IDXX) Investor Outlook: Exploring a 19.21% Upside Potential

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the healthcare sector, specifically within diagnostics and research, is currently capturing the attention of investors with its promising potential for growth...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds